Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/1995
11/23/1995WO1995031555A1 Fusion glycoprotein from hcmv and hsv
11/23/1995WO1995031553A1 DNA SEQUENCES CODING FOR ENZYMES CAPABLE OF FACILITATING THE SYNTHESIS OF LINEAR α-1,4 GLUCANS IN PLANTS, FUNGI AND MICROORGANISMS
11/23/1995WO1995031551A1 Novel enzymatic rna molecules
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031470A2 Antisense inhibitors of gene expression
11/23/1995WO1995031469A1 Pteridine nucleotide analogs as fluorescent dna probes
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031459A1 Morpholino-subunit combinatorial library and method
11/23/1995WO1995031434A1 Complementary dna and toxins
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995CA2578402A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2201772A1 Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
11/23/1995CA2190529A1 Fusion glycoprotein from hcmv and hsv
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190145A1 Complementary dna and toxins
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995CA2186615A1 Novel enzymatic rna molecules
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0682716A1 Rna assays using rna binary probes and ribozyme ligase
11/22/1995EP0682715A1 Diagnostic assays and kits for rna using rna binary probes and an rna-directed rna ligase
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products
11/22/1995EP0682671A1 Methods and apparatus for dna sequencing
11/22/1995CN1112126A Polyamid-oligonucleotide derivative, preparation and application of same
11/22/1995CN1112124A Process for extracting deoxyribonucleic acid (DNA)
11/21/1995US5468646 Chemiluminescent acridinium salts
11/21/1995US5468609 Production of interferon
11/21/1995US5468608 Production of interferon
11/21/1995US5468607 Production of interferon
11/18/1995CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
11/16/1995WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030751A1 Lanthionine-containing antimicrobial compound
11/16/1995WO1995030746A1 Antisense inhibition of hepatitis c virus
11/16/1995WO1995030433A1 A novel brain endothelial cell protein and methods for its use
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995019371A3 Expression of surface layer proteins
11/16/1995CA2190027A1 A novel brain endothelial cell protein and methods for its use
11/16/1995CA2186621A1 Lanthionine-containing antimicrobial compound
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682120A1 Selective amplification of target polynucleotide sequences
11/15/1995EP0681613A1 Ribozyme amplified diagnostics
11/15/1995EP0681586A1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds
11/15/1995EP0681477A1 Genetic modification of neural stem cells
11/15/1995EP0681431A1 Production of human recombinant collagen in the milk of transgenic animals
11/15/1995EP0577771A4 Analytical methods for identifying chromosomal aberrations
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/14/1995US5466786 2'modified nucleoside and nucleotide compounds
11/14/1995US5466677 Dinucleoside phosphinates and their pharmaceutical compositions
11/14/1995US5466608 Process and apparatus for heterogeneous phase synthesis of macromolecules such as peptides, polynucloetides or oligosaccharides
11/14/1995US5466596 Genetic engineering
11/14/1995US5466577 Nucleic acid probes for the detection of Lyme disease spirochetes
11/14/1995CA1337551C Accelerated nucleic acid reassociation method
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995029930A2 Improved method for oligonucleotide analog synthesis
11/09/1995WO1995029921A1 Activated esters of 1-phenylpyrazolin-5-one for labelling amine-functionalized molecules
11/09/1995WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/08/1995EP0681027A2 Plasmid vector and its use for the production of heterologous proteins
11/08/1995EP0680969A2 Modified oligonucleotides, their preparation and their use
11/08/1995EP0680518A1 Detection of synthetic oligonucleotides extracted from body fluids or tissues.
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995CN1111249A TTTr as protective group in nucleotide synthesis
11/07/1995US5464826 Antitumor, anticarcinogenic agents, treatment of herpes
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/07/1995US5464746 Nucleic acid hybridization
11/07/1995US5464743 Detecting yeast
11/03/1995CA2148312A1 Modified oligonucleotides, their preparation and their use
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029184A1 Polycationic nucleic bases and oligonucleotides containing same
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995028942A1 Antisense oligomers for inhibiting human papillomaviruses
11/02/1995WO1995028941A1 Composition and method for treatment of cmv infection
11/02/1995WO1995027718A3 Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679657A2 Nucleosides and oligonucleotides containing 2'-ether groups
11/02/1995EP0679196A1 Dna sequencing by mass spectrometry
1 ... 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 ... 899